CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 292 | -98.5% | 0.00% | – |
| Q2 2023 | $28,000 | -9.7% | 19,299 | +1.7% | 0.00% | – |
| Q1 2023 | $31,000 | -3.1% | 18,982 | -17.4% | 0.00% | – |
| Q4 2022 | $32,000 | -22.0% | 22,982 | -14.4% | 0.00% | – |
| Q3 2022 | $41,000 | -31.7% | 26,848 | -0.1% | 0.00% | – |
| Q2 2022 | $60,000 | -27.7% | 26,866 | -19.4% | 0.00% | – |
| Q1 2022 | $83,000 | -71.9% | 33,337 | -32.1% | 0.00% | – |
| Q4 2021 | $295,000 | +35.9% | 49,072 | +50.4% | 0.00% | – |
| Q3 2021 | $217,000 | +141.1% | 32,632 | +138.6% | 0.00% | – |
| Q2 2021 | $90,000 | -31.3% | 13,675 | -3.7% | 0.00% | – |
| Q1 2021 | $131,000 | -20.1% | 14,200 | +55.7% | 0.00% | – |
| Q4 2020 | $164,000 | +485.7% | 9,119 | +356.0% | 0.00% | – |
| Q3 2020 | $28,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |